The nonprofit Claire’s Place Foundation has launched a pilot program to help 15 adults with cystic fibrosis (CF) or…
Articles by Inês Martins, PhD
A Phase 1/2 clinical trial assessing Arrowhead Pharmaceuticals‘ investigational inhaled therapy, ARO-ENaC, for the treatment of cystic…
The Cystic Fibrosis Foundation has committed $20 million to support the development of innovative therapeutics and early-stage companies focusing…
A national newborn screening (NBS) program in the Republic of Ireland suggests that the incidence of cystic fibrosis and…
ContraFect has been awarded to $18.9 million by the nonprofit investment group CARB-X to advance CF-370 as a potential…
AR-501, an inhaled treatment candidate for chronic lung infections in people with cystic fibrosis (CF), has been deemed…
A combination of two mutations, including one that had never been reported, were found in two Chinese siblings who developed…
Microbion has been awarded up to $17.1 million from the nonprofit CARB-X and the Cystic Fibrosis Foundation…
In addition to restoring CFTR protein function in cells, the cystic fibrosis (CF) therapies Orkambi (lumacaftor/ivacaftor)…
Oxford Hospitals Charity has purchased and delivered machines able to measure lung function at home to 120 young patients…